Learn More
Gibco™ Human VEGF-165 Recombinant Protein, PeproTech®
Recombinant Protein
836.00 NOK - 40420.00 NOK
Specifications
Accession Number | P15692 |
---|---|
For Use With (Application) | ELISA, Functional Assay, Western Blot |
Formulation | protein with no preservative |
Gene ID (Entrez) | 7422 |
Molecular Weight (g/mol) | 38.2 kDa |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
17821473
|
Gibco™
100-20-100UG |
100 ÎĽg |
8080.00 NOK
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17861763
|
Gibco™
100-20-10UG |
10 ÎĽg |
2035.00 NOK
10µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17800953
|
Gibco™
100-20-1MG |
1 mg |
40420.00 NOK
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17839922
|
Gibco™
100-20-250UG |
250 ÎĽg |
14190.00 NOK
250µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17819912
|
Gibco™
100-20-2UG |
2 ÎĽg |
836.00 NOK
2µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17820873
|
Gibco™
100-20-500UG |
500 ÎĽg |
24310.00 NOK
500µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
17809912
|
Gibco™
100-20-50UG |
50 ÎĽg |
4825.00 NOK
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Recombinant Human VEGF 165 is a 38.2 kDa, disulfide-linked homodimeric protein consisting of two 165 amino acid polypeptide chains. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
The vascular endothelial growth factor (VEGF) family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis. Most tumors have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine linked to this process. To date 5 different isoforms of VEGF have been described. These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells.Specifications
P15692 | |
protein with no preservative | |
38.2 kDa | |
E. coli | |
<1 EU/ ÎĽg | |
VEGF-165 | |
Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml | |
Recombinant | |
-20°C | |
Lyophilized |
ELISA, Functional Assay, Western Blot | |
7422 | |
Human VEGF-165 | |
RUO | |
H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF | |
VEGFA | |
Unconjugated | |
APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR | |
E. coli | |
≥ 98% by SDS-PAGE gel and HPLC analyses. |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.